Phenotypic screening with target identification and validation in the discovery and development of E3 ligase modulators.

Abstract excerpt

The use of phenotypic screening was central to the discovery and development of novel thalidomide analogs, the IMiDs (immunomodulatory drugs) agents. With the discovery that these agents bind the E3 ligase, CRL4CRBN, and alter its substrate specificity, there has been a great deal of endeavor to discover other small molecules that can modulate alternative E3 ligases. Furthermore, the chemical properties necessary...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Development
• Share to Drug Evaluation, Preclinical